RB1 c.2323dup ;(p.R775Kfs*20)

Variant ID: 13-49039244-C-CA

NM_000321.2(RB1):c.2323dup;(p.R775Kfs*20)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


PI3K-AKT-mTOR pathway alterations in advanced NSCLC patients after progression on EGFR-TKI and clinical response to EGFR-TKI plus everolimus combination therapy.

Translational Lung Cancer Research
Fang, Wenfeng W; Huang, Yihua Y; Gu, Weiguang W; Gan, Jiadi J; Wang, Wenjing W; Zhang, Shiyue S; Wang, Kai K; Zhan, Jianhua J; Yang, Yunpeng Y; Huang, Yan Y; Zhao, Hongyun H; Zhang, Li L
Publication Date: 2020-08

Variant appearance in text: RB1: Arg775fs
PubMed Link: 32953503
Variant Present in the following documents:
  • Main text
  • tlcr-09-04-1258.pdf
View BVdb publication page